Skip to content

A randomized controlled trial of the treatment of stress urinary incontinence in women by acupuncture at the ZhongJi point under CT location

A randomized controlled trial of the treatment of stress urinary incontinence in women by acupuncture at the ZhongJi point under CT location

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075342
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SUI

Interventions

Treatment Group 1:Acupuncture was applied to Zhongji point to the anterior bladder space.
Treatment Group 2:Acupuncture was applied at Zhongji point to 1cm below the abdominal wall.
Control group:Acupuncture was applied to Zhongji point to the fat layer.

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) in accordance with the fourth international incontinence recommendations (4 th Edition 2009). ? Symptoms: when the abdominal pressure increases in various degrees, such as sneezing, coughing, laughing, strenuous exercise or walking, urine leakage is involuntary. When the abdominal pressure is stopped, urine flow is stopped. ? Signs: involuntary urine leakage when abdominal pressure increased, or weight gain >1g in pad test; ? No accompanying symptoms such as urgency and frequency of urination. (2) the age is greater than 35 years old and less than 65 years old; (3) signed informed consent and were willing to participate in the study.

Exclusion criteria

Exclusion criteria: (1) patients with other types of urinary incontinence, such as overflow urinary incontinence, mixed urinary incontinence and urge urinary incontinence; (2) is a former incontinence surgery or pelvic surgery; (3) limited or unable to run, exercise, or even go up and down stairs; (4) Qmax 30ml; (6) vaginal, pelvic and urinary tract infections; (7) with nervous system disease, diabetes, history affect micturition function; (8) malignant wasting diseases such as uterine fibroids, ovarian cancer and tuberculosis; (9) with hepatic and renal dysfunction and other cardiopulmonary disease, blood disease and other serious diseases; (10) ultrasound findings on urinary tract obstruction seeper, kidney function is damaged; (11) nearly 1 month affect bladder function of drugs or SUI related treatment; (12) patients with long-term use of anticoagulant drugs and severe anemia; (13) nearly 1 month to participate in other clinical trials; (14) pregnant women with the need for pregnancy preparation within 3 months; (15) was judged by the investigator to be ineligible for trial participation.

Design outcomes

Primary

MeasureTime frame
1h pad test;International Advisory Committee on Incontinence Urinary Incontinence Questionnaire-short form;

Countries

China

Contacts

Public ContactYonghui Lu

Xiyuan Hospital, China Academy of Chinese Medical Sciences

yhlu2008@sina.com+86 135 2177 6025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026